Axial Therapeutics announced it is expanding the age eligibility criterion to include children ages 5 to 17 years in...
Read more
Axial Therapeutics announced key promotions in its research and development organization. These promotions recognize the Axial team’s scientific and...
Read more
MemVerge attends MemCon to demonstrate the capacity and performance benefits of Compute Express Link™ (CXL™) memory. The demo features a...
Read more
TechArena host Allyson Klein chats with MemVerge founder and CEO Charles Fan about his company’s disruptive vision for breaking...
Read more
PteroDynamics announced the appointment of Richard Brasel as its Chief Revenue Officer. Brasel brings with him a wealth of...
Read more
PteroDynamics announced the close of a $7.5 million Seed round. The round was co-led by existing investor Kairos Ventures...
Read more
Tempus announced a brand-new multi-omics collaboration with Actuate Therapeutics to support its ongoing Phase 1/2 Study of elraglusib, formerly...
Read more
Becky Schultz speaks with founder and CEO of Transient Plasma Systems, Dan Singleton, about the company’s plasma-based aftertreatment and...
Read more
Linnaeus Therapeutics announced that the FDA has granted orphan drug designation for LNS8801 for the treatment of patients with...
Read more
MemVerge announced that Jeffrey Wang has been named Vice President of Engineering. With decades of software-defined infrastructure experience across...
Read more